Vivek Ramaswamy, a former presidential candidate, is expected to announce his campaign for Ohio governor in 2026. In 2014 Ramaswamy co-founded Roivant Sciences, which buys or licenses promising ...

Vivek Ramaswamy, a former presidential candidate, is expected to announce his campaign for Ohio governor in 2026. In 2014 Ramaswamy co-founded Roivant Sciences, which buys or licenses promising ...

In 2015, Ramaswamy cashed out a piece of his Roivant stake, accounting for the majority of his nearly $37.1 million in capital gains on his tax return.

In 2014, at the age of 29, Ramaswamy founded Roivant Sciences, a pharmaceutical company. By 2023, he had made at least $250 million in personal income from his business ventures.

Also Read: Vivek Ramaswamy-Founded Roivant’s Anti-Inflammatory Drug Aces Mid-Stage Study. As previously disclosed, the batoclimab phase 2a trial in uncontrolled Graves’ Disease enrolled p ...

Vivek Ramaswamy offloads $33M Roivant stock Jan. 04, 2024 2:57 PM ET Roivant Sciences Ltd. (ROIV) Stock By: Dulan Lokuwithana, SA News Editor 27 Comments ...

In addition to Roivant, Ramaswamy holds an estimated $220 million in stocks, bonds and other investments. And his second largest holding, Strive Asset Management, appears to be doing well.

It has been a pretty bad year for biotech stocks. Roivant Sciences, the biotech holding company founded by Republican presidential candidate Vivek Ramaswamy at age 29, has been a notable exception.

Vivek’s views on FDA are different than my personal views on FDA and different than Roivant’s views on FDA.” “We have an enormous amount of respect for FDA as our regulator,” he added.

While Ramaswamy vocally opposes ESG principles, Roivant's major institutional investors—including Morgan Stanley, Viking Global, and BlackRock, the very firms he criticizes by name—are among ...

Ramaswamy’s 10% stake in the company, which had a market capitalization of $8.87 billion as of Thursday morning, translates into $887 million on paper. So far this year, Roivant’s stock price ...

Vivek Ramaswamy, founder of Roivant Sciences. Lisa Lake/Getty Images Seven years ago, Vivek Ramaswamy created Roivant Sciences with the aim of finding a new financial model for drug development.